BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36588357)

  • 1. LncRNA colorectal neoplasia differentially expressed promotes glycolysis of liver cancer cells by regulating hypoxia-inducible factor 1α.
    Tang D; Zhao L; Mu R; Ao Y; Zhang X; Li X
    Chin J Physiol; 2022; 65(6):311-318. PubMed ID: 36588357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
    Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
    J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, invasion, and migration through regulating miR-203/ BCAT1 axis.
    Ji D; Jiang C; Zhang L; Liang N; Jiang T; Yang B; Liang H
    J Cell Physiol; 2019 May; 234(5):6548-6560. PubMed ID: 30230527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of long noncoding RNA colorectal neoplasia differentially expressed inhibits hepatocellular carcinoma progression by mediating the expression of nuclear autoantigenic sperm protein.
    Zhu Y; Li B; Xu G; Han C; Xing G
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34633056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma.
    Xie SC; Zhang JQ; Jiang XL; Hua YY; Xie SW; Qin YA; Yang YJ
    Cell Death Dis; 2020 Aug; 11(8):676. PubMed ID: 32826865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism.
    Ellis BC; Graham LD; Molloy PL
    Biochim Biophys Acta; 2014 Feb; 1843(2):372-86. PubMed ID: 24184209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression.
    Ding J; Li J; Wang H; Tian Y; Xie M; He X; Ji H; Ma Z; Hui B; Wang K; Ji G
    Cell Death Dis; 2017 Aug; 8(8):e2997. PubMed ID: 28796262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
    Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
    Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
    Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
    Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of lncRNA NORAD accounts for hypoxia-induced chemoresistance and vasculogenic mimicry in colorectal cancer by sponging the miR-495-3p/ hypoxia-inducible factor-1α (HIF-1α).
    Zhang L; Wu H; Zhang Y; Xiao X; Chu F; Zhang L
    Bioengineered; 2022 Jan; 13(1):950-962. PubMed ID: 34969360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CRNDE sponges miR-384 to promote proliferation and metastasis of pancreatic cancer cells through upregulating IRS1.
    Wang G; Pan J; Zhang L; Wei Y; Wang C
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28940804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Noncoding RNA Colorectal Neoplasia Differentially Expressed Gene as a Potential Target to Upregulate the Expression of IRX5 by miR-136-5P to Promote Oncogenic Properties in Hepatocellular Carcinoma.
    Zhu L; Liu Y; Chen Q; Yu G; Chen J; Chen K; Yang N; Zeng T; Yan S; Huang A; Tang H
    Cell Physiol Biochem; 2018; 50(6):2229-2248. PubMed ID: 30423553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
    Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA CRNDE Promotes Proliferation of Gastric Cancer Cells by Targeting miR-145.
    Hu CE; Du PZ; Zhang HD; Huang GJ
    Cell Physiol Biochem; 2017; 42(1):13-21. PubMed ID: 28490034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRNDE promotes cell tongue squamous cell carcinoma cell growth and invasion through suppressing miR-384.
    Ren Y; He W; Chen W; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Chai J; Sun M
    J Cell Biochem; 2019 Jan; 120(1):155-163. PubMed ID: 30242873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lncRNA coordinates with Ezh2 to inhibit HIF-1α transcription and suppress cancer cell adaption to hypoxia.
    Wang X; Wang Y; Li L; Xue X; Xie H; Shi H; Hu Y
    Oncogene; 2020 Feb; 39(9):1860-1874. PubMed ID: 31784651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
    Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
    J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long non-coding RNA CRNDE competed endogenously with miR-205 to promote proliferation and metastasis of melanoma cells by targeting CCL18.
    Xu L; Zhang Y; Zhao Z; Chen Z; Wang Z; Xu S; Zhang X; Liu T; Yu S
    Cell Cycle; 2018; 17(18):2296-2308. PubMed ID: 30257602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.
    Zheng J; Li XD; Wang P; Liu XB; Xue YX; Hu Y; Li Z; Li ZQ; Wang ZH; Liu YH
    Oncotarget; 2015 Sep; 6(28):25339-55. PubMed ID: 26231038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
    Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
    J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.